Table of Contents How MASLD Presents Beyond Traditional Risk Factors Why GLP1s Are Gaining Attention in Liver Disease Recognizing Lean Liver Disease in Clinical Practice Integrating GLP1s into a LiverFirst Treatment Strategy Evidence Summary: What the Data Suggest Practical Considerations for Clinicians How MASLD Presents Beyond Traditional Risk Factors MASLD encompasses a spectrum from simple steatosis to inflammatory and fibrotic disease (NASH)
A: Semaglutide is a medication that mimics a natural hormone called GLP-1, which regulates appetite and food intake
It plays a crucial role in many of your body's functions
According to the American Society for Metabolic and Bariatric Surgery, surgical patients lose up to five times more weight at two years compared to those using semaglutide or tirzepatide, with sustained benefits for a decade or more, whereas most medication users regain weight once treatment stops
If constipation persists, ask your clinician about safe OTC options
3 Endocrine dysfunction, including goiter, hypothyroidism, and calcium metabolism abnormalities, has occasionally been documented